Clinical Trial Update: AMG 102 and Avastin for Recurrent Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial results for AMG 102 in combination with Avastin (bevacizumab) for recurrent malignant glioma have been posted. The study included patients with gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• AMG 102 (AMG 102)
• Avastin (bevacizumab)

Snippet

Sponsor: Katy Peters | Conditions: Glioblastoma Multiforme, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2015-12-10